Výsledky vyhľadávania - "The Lancet (British edition)"
-
1
Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
ISSN: 0140-6736, 1474-547X, 1474-547XVydavateľské údaje: England Elsevier Ltd 10.08.2024Vydané v The Lancet (British edition) (10.08.2024)“…Evidence is increasing and is now stronger than before that tackling the many risk factors for dementia that we modelled previously (ie, less education,…”
Získať plný text
Journal Article -
2
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
ISSN: 1474-547X, 0140-6736, 1474-547XVydavateľské údaje: Amsterdam Elsevier 15.07.2023Vydané v The Lancet (British edition) (15.07.2023)“…Diabetes is one of the leading causes of death and disability worldwide, and affects people regardless of country, age group, or sex. Using the most recent…”
Získať plný text
Journal Article -
3
Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019
ISSN: 0140-6736, 1474-547X, 1474-547XVydavateľské údaje: England Elsevier Ltd 17.12.2022Vydané v The Lancet (British edition) (17.12.2022)“…Reducing the burden of death due to infection is an urgent global public health priority. Previous studies have estimated the number of deaths associated with…”
Získať plný text
Journal Article -
4
Ulcerative colitis
ISSN: 0140-6736, 1474-547X, 1474-547XVydavateľské údaje: England Elsevier Ltd 12.08.2023Vydané v The Lancet (British edition) (12.08.2023)“…Ulcerative colitis is a lifelong inflammatory disease affecting the rectum and colon to a variable extent. In 2023, the prevalence of ulcerative colitis was…”
Získať plný text
Journal Article -
5
Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021
ISSN: 0140-6736, 1474-547X, 1474-547XVydavateľské údaje: England Elsevier Ltd 18.05.2024Vydané v The Lancet (British edition) (18.05.2024)“…Future trends in disease burden and drivers of health are of great interest to policy makers and the public at large. This information can be used for policy…”
Získať plný text
Journal Article -
6
Hepatocellular carcinoma
ISSN: 0140-6736, 1474-547X, 1474-547XVydavateľské údaje: London Elsevier Limited 15.10.2022Vydané v The Lancet (British edition) (15.10.2022)“…Summary Hepatocellular carcinoma is one of the most common cancers worldwide and represents a major global health-care challenge. Although viral hepatitis and…”
Získať plný text
Journal Article -
7
The 2023 report of the Lancet Countdown on health and climate change: the imperative for a health-centred response in a world facing irreversible harms
ISSN: 0140-6736, 1474-547X, 1474-547XVydavateľské údaje: England Elsevier Ltd 16.12.2023Vydané v The Lancet (British edition) (16.12.2023)“…In 2022, the Lancet Countdown warned that people's health is at the mercy of fossil fuels and stressed the transformative opportunity of jointly tackling the…”
Získať plný text
Journal Article -
8
National, regional, and global estimates of preterm birth in 2020, with trends from 2010: a systematic analysis
ISSN: 0140-6736, 1474-547X, 1474-547XVydavateľské údaje: England Elsevier Ltd 07.10.2023Vydané v The Lancet (British edition) (07.10.2023)“…Preterm birth is the leading cause of neonatal mortality and is associated with long-term physical, neurodevelopmental, and socioeconomic effects. This study…”
Získať plný text
Journal Article -
9
Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants
ISSN: 0140-6736, 1474-547X, 1474-547XVydavateľské údaje: England Elsevier Ltd 23.11.2024Vydané v The Lancet (British edition) (23.11.2024)“…Diabetes can be detected at the primary health-care level, and effective treatments lower the risk of complications. There are insufficient data on the…”
Získať plný text
Journal Article -
10
The pathogenesis of Parkinson's disease
ISSN: 0140-6736, 1474-547X, 1474-547XVydavateľské údaje: England Elsevier Ltd 20.01.2024Vydané v The Lancet (British edition) (20.01.2024)“…Parkinson's disease is a progressive neurodegenerative condition associated with the deposition of aggregated α-synuclein. Insights into the pathogenesis of…”
Získať plný text
Journal Article -
11
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
ISSN: 0140-6736, 1474-547X, 1474-547XVydavateľské údaje: England Elsevier Ltd 03.06.2023Vydané v The Lancet (British edition) (03.06.2023)“…Biliary tract cancers, which arise from the intrahepatic or extrahepatic bile ducts and the gallbladder, generally have a poor prognosis and are rising in…”
Získať plný text
Journal Article -
12
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial
ISSN: 0140-6736, 1474-547X, 1474-547XVydavateľské údaje: England Elsevier Ltd 23.04.2022Vydané v The Lancet (British edition) (23.04.2022)“…Lobectomy is the standard of care for early-stage non-small-cell lung cancer (NSCLC). The survival and clinical benefits of segmentectomy have not been…”
Získať plný text
Journal Article -
13
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial
ISSN: 0140-6736, 1474-547X, 1474-547XVydavateľské údaje: England Elsevier Ltd 03.07.2021Vydané v The Lancet (British edition) (03.07.2021)“…First-line chemotherapy for advanced or metastatic human epidermal growth factor receptor 2 (HER2)-negative gastric or gastro-oesophageal junction…”
Získať plný text
Journal Article -
14
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
ISSN: 0140-6736, 1474-547X, 1474-547XVydavateľské údaje: England Elsevier Ltd 09.01.2021Vydané v The Lancet (British edition) (09.01.2021)“…A safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the…”
Získať plný text
Journal Article -
15
Non-alcoholic fatty liver disease
ISSN: 0140-6736, 1474-547X, 1474-547XVydavateľské údaje: England Elsevier Ltd 05.06.2021Vydané v The Lancet (British edition) (05.06.2021)“…Non-alcoholic fatty liver disease (NAFLD) has a global prevalence of 25% and is a leading cause of cirrhosis and hepatocellular carcinoma. NAFLD encompasses a…”
Získať plný text
Journal Article -
16
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
ISSN: 0140-6736, 1474-547X, 1474-547XVydavateľské údaje: England Elsevier Limited 16.01.2021Vydané v The Lancet (British edition) (16.01.2021)“…The long-term health consequences of COVID-19 remain largely unclear. The aim of this study was to describe the long-term health consequences of patients with…”
Získať plný text
Journal Article -
17
Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study
ISSN: 0140-6736, 1474-547X, 1474-547XVydavateľské údaje: England Elsevier Ltd 02.04.2022Vydané v The Lancet (British edition) (02.04.2022)“…The omicron variant (B.1.1.529) of SARS-CoV-2 has demonstrated partial vaccine escape and high transmissibility, with early studies indicating lower severity…”
Získať plný text
Journal Article -
18
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
ISSN: 0140-6736, 1474-547X, 1474-547XVydavateľské údaje: England Elsevier Ltd 30.09.2023Vydané v The Lancet (British edition) (30.09.2023)“…Immunotherapy with immune checkpoint inhibitors combined with an anti-angiogenic tyrosine-kinase inhibitor (TKI) has been shown to improve overall survival…”
Získať plný text
Journal Article -
19
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial
ISSN: 0140-6736, 1474-547X, 1474-547XVydavateľské údaje: England Elsevier Ltd 03.12.2022Vydané v The Lancet (British edition) (03.12.2022)“…There is a paucity of evidence for dose and pace of up-titration of guideline-directed medical therapies after admission to hospital for acute heart failure…”
Získať plný text
Journal Article -
20
Type 2 diabetes
ISSN: 0140-6736, 1474-547X, 1474-547XVydavateľské údaje: England Elsevier Ltd 19.11.2022Vydané v The Lancet (British edition) (19.11.2022)“…Type 2 diabetes accounts for nearly 90% of the approximately 537 million cases of diabetes worldwide. The number affected is increasing rapidly with alarming…”
Získať plný text
Journal Article